CirrusDx Acquires Dascena's Texas Laboratory Business, Expanding Infectious Disease Portfolio
ROCKVILLE, Md., Aug. 3, 2022 /PRNewswire/ -- Cirrus Dx, Inc. ("CirrusDx"), an infectious disease diagnostics and laboratory company, announces the ...
ROCKVILLE, Md., Aug. 3, 2022 /PRNewswire/ -- Cirrus Dx, Inc. ("CirrusDx"), an infectious disease diagnostics and laboratory company, announces the acquisition of Dascena Inc.'s Houston-based laboratory business, Dascena Labs, LLC ("Dascena Labs"). Through the acquisition CirrusDx will enhance its current services by further expanding its national laboratory footprint, while strengthening its sequencing capabilities. Dascena Labs is a state-of-the-art CLIA laboratory capable of high-volume specialized testing.